Iridex (IRIX) Net Income towards Common Stockholders Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.19% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.89% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 29.56% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | 36.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 36.94% |
| Jan 3, 2026 | 81.93% |
| Sep 27, 2025 | 3.80% |
| Jun 28, 2025 | 23.74% |
| Mar 29, 2025 | 10.99% |
| Dec 28, 2024 | 8.41% |
| Sep 28, 2024 | 3.71% |
| Jun 29, 2024 | -57.72% |
| Mar 30, 2024 | -19.89% |
| Sep 30, 2023 | -0.67% |
| Jul 1, 2023 | 0.17% |
| Apr 1, 2023 | -8.18% |
| Dec 31, 2022 | -29.45% |
| Oct 1, 2022 | 0.34% |
| Jul 2, 2022 | 2.52% |
| Apr 2, 2022 | 7.77% |
| Jan 1, 2022 | -14.38% |
| Oct 2, 2021 | 11.03% |
| Jul 3, 2021 | 34.34% |
| Apr 3, 2021 | 17.68% |
| Sep 26, 2020 | 17.81% |
| Jun 27, 2020 | -0.36% |
| Mar 28, 2020 | 4.00% |
| Dec 28, 2019 | 38.58% |
| Sep 28, 2019 | -38.56% |
| Jun 29, 2019 | -94.65% |
| Mar 30, 2019 | -218.07% |
| Dec 29, 2018 | 142.55% |
| Sep 29, 2018 | -107.66% |
| Jun 30, 2018 | -71.35% |
| Mar 31, 2018 | -155.33% |
| Sep 30, 2017 | -102.62% |
| Jul 1, 2017 | -124.13% |
| Apr 1, 2017 | -80.00% |
| Dec 31, 2016 | -204.56% |
| Jan 2, 2016 | -32.95% |
| Oct 3, 2015 | 62.94% |
| Apr 4, 2015 | 52.10% |
| Jun 28, 2014 | 96.74% |